ClinicalTrials.gg
RecruitingNCT07824141Updated Nov 18, 2026

Fall Prevention Pathways

An interventional study of The Fall Prevention Pathway (FPP) in Old Age; Debility, sponsored by Emory University. Recruiting at 1 site in United States. Open to participants aged 65 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Emory University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Sep 2025, registered Sep 2026).
  • Started Sep 2025; still recruiting 1 year 1 month later.
Updated Nov 18, 2026Primary outcomes revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
65 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 185 studies in Frailty with a site in United States — 48 open to participants now, 61 under way, 1 of them phase 3. Frailty · United States.

Planned enrollment
64th of 142
50 · median 42
Started
2025
with 11 others
No phase
93 of 185
27 open now
Primary completion
2028-09
later than 49 of 59 live
Registered
185th of 185
by date

Among the 185 studies in Frailty with a site in United States, this one is the 64th largest by planned enrollment of the 142 interventional ones that give a count, is one of 12 that started in 2025, is one of 93 with no phase, reaches primary completion later than 49 of the 59 other live ones, and was the 185th registered.

Frailty

1,288 studies on the registry are indexed under Frailty; 455 are open to participants now.

Browse Frailty studies →

Open to participants now

48 of the 185 studies in Frailty with a site in United States are open now. Recruiting first, the newest first:

42 more — sign in →

All 48 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 301 Frailty studies recruiting now, 236 (78%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 67 take healthy volunteers.

This study: 65 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Frailty with a site in United States, or all of them as a file.
02

Study summary

Falls are a leading cause of injury and loss of independence in older adults, with evidence supporting exercise-based interventions and remote monitoring as effective strategies for reducing fall risk. However, adherence and engagement with such programs remain significant challenges.

This study builds on prior research demonstrating the feasibility of digital health interventions in rehabilitation and extends it to a structured, remotely monitored Fall Prevention Pathway (FPP). Preliminary work in digital rehabilitation has shown positive engagement and clinical outcomes, supporting the need for further exploration of feasibility, adherence, and cost implications of remotely monitored fall prevention programs.

Read the detailed description

This study will evaluate the Fall Prevention Pathways (FPP) program, a digital rehabilitation intervention that assesses the impact of remote monitoring in reducing fall risk in community-dwelling older adults.

Participants will be enrolled in an 8-week intervention and followed for an additional 6 months. The study will assess feasibility, patient adherence, engagement, clinical outcomes, and cost implications. Data collection will occur at baseline (0 weeks), post-intervention (8 weeks), and follow-ups at 13 weeks (3 months) and 26 weeks (6 months).

03

Conditions studied

  • Old Age; Debility

Browse trials for

Keywords

  • Older adults
  • Fall risk
  • Digital Program
04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 65-85 years
  • Community-dwelling individuals classified as low to moderate fall risk based on standardized assessments, (i.e., the Stay Independent Screener)
  • Ability to ambulate independently or with a single-point cane
  • Willingness to participate in an 8-week intervention with remote monitoring
  • Access to a smartphone, tablet, or computer with internet connectivity
  • Ability to provide

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment or a diagnosis of dementia that would affect adherence or ability to provide consent
  • Neurological or vestibular disorders (e.g., Parkinson's disease, multiple sclerosis, history of stroke with residual balance impairment)
  • Severe comorbidities that significantly impact mobility and function (e.g., recent orthopedic surgery, unstable cardiac conditions)
  • Significant visual or hearing impairments that prevent engagement with digital health interventions
  • Non-ambulatory or requiring assistance of another person for mobility
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    The Fall Prevention Pathway (FPP)

    Participants will be enrolled in an 8-week FPP intervention program. After completing the 8-week FPP intervention, participants will undergo long-term follow-up assessments at 8 weeks, 13 weeks (3 months), and 26 weeks (6 months) post-intervention. The follow-up assessments aim to assess sustained engagement, adherence, clinical outcomes, and fall incidence.

    Behavioral: The Fall Prevention Pathway (FPP)

Interventions

  • BehavioralThe Fall Prevention Pathway (FPP)

    The Fall Prevention Pathway (FPP) is a digital progression of exercises \& patient education delivered through a web platform designed to improve balance, boost confidence, and reduce fall risk. The FPP enrolls participants in a Medbridge Pathway and provides remote monitoring by a clinician who personalizes programs and provides verbal education to help reduce fall risk.

06

What researchers measure

Primary outcomes

  1. Number of participants who complete the intervention

    The feasibility of the study is assessed by the number of participants retained through the 8-week intervention. The study is determined to be feasible if 80 percent of recruited participants complete the intervention.

    Time frame: 8 weeks

  2. Adherence to program

    Adherence will be measured as the proportion of participants who complete at least 3 days of activity per week per week among those who initiated the intervention.

    Time frame: At the end of the intervention (8 weeks)

Secondary outcomes

  1. 30-Second Sit-to-Stand test

    The number of sit-to-stand maneuvers completed in 30 seconds is used to measure leg strength and endurance. A higher score is better.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  2. Gait speed over 20 feet

    Gait speed testing (Forward/Backwards/Fast): How quickly a person can walk within a 20-foot distance forward and Backwards using GAITRite. GAITRite is a pressure-sensitive walkway that can assess gait anomalies. Lower scores are better.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  3. Timed Up and Go Simple and Dual tasks (TUG, TUG Cognitive and TUG Manual)

    Measures the time it takes to rise from a chair, walk 3 meters, turn around, and return to the chair in the simple condition. In the Cognitive condition, one is required to simultaneously count backward by 3s from a number between 20 and 100; in the Manual condition, one is required to simultaneously pick up a cup of water and carry it while completing the task. A lower score is a better outcome.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  4. Tandem stance (from 4 stage balance test),

    The tandem stance in the 4-Stage Balance Test is a static balance position where the participant stands with one foot directly in front of the other, with the heel of the front foot touching the toes of the back foot. It assesses static balance and postural stability by significantly narrowing your base of support. Screens for fall risk, specifically in older adults. Scoring: Time tracked: Measured using a stopwatch up to 10 seconds with eyes open. Pass criteria: Must maintain the heel-to-toe position for 10 full seconds without moving the feet or grabbing support/the tester. Stop condition: The test stops immediately if the person cannot reach the 10-second mark, meaning their final score is recorded at the highest stage successfully completed.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  5. Short Form 12-Quality of Life (SF12)

    The SF12 evaluates the level of activity and perceived physical and mental quality of life. The SF-12 uses a standardized system with scores ranging from 0 to 100, where the general population's average is 50, with higher scores indicating better health. Because it measures relative deviation, the numbers represent the following health levels: Above 50: Better than average health. Exactly 50: Average health status. 40 to 50: Below average health (mild disability or impairment). 30 to 40: Moderate disability or impairment. Below 40: Severe impairment or disability.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  6. Falls Efficacy Scale (FES-I)

    The Falls Efficacy Scale-International (FES-I) measures a person's level of concern or fear about falling while performing 16 everyday indoor and outdoor activities. Each activity is rated on a 4-point Likert scale from 1 to 4; with 1 = Not at all concerned; 2 = Somewhat concerned; 3 = Fairly concerned and 4 = Very concerned. All 16 item scores are added together for the final sum. Minimum Score: 16 (indicates no concern about falling) Maximum Score: 64 (indicates severe or extreme concern about falling)

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  7. Activities-specific Balance Confidence Scale (ABC)

    The Activities-specific Balance Confidence (ABC) Scale is a 16-item self-report questionnaire used to measure an individual's confidence in performing daily activities without losing their balance or feeling unsteady. Participants rate their self-confidence on a percentage scale from 0% (no confidence) to 100% (completely confident) for 16 specific tasks. The total score is added for all 16 items and divided by 16 to get the average percentage score. ≥ 80%: Indicates a high level of physical functioning and balance confidence. 50% to 80%: Indicates a moderate level of physical functioning. \< 50%: Indicates a low level of physical functioning. Higher scores indicate a higher level of functioning and a lower risk of falling, while lower scores (below 67%) often indicate a higher risk of falling. Score Interpretation: 16-19: Low concern about falling 20-27: Moderate concern about falling 28-64: High concern about falling

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  8. Physical Activity Scale for the Elderly (PASE)

    The PASE score combines information on leisure, household, and occupational activity. The PASE assesses the types of activities typically chosen by older adults (walking, recreational activities, exercise, housework, yard work, and caring for others. It uses frequency, duration, and intensity level of activity over the previous week to assign a score, ranging from 0 to 793, with higher scores indicating greater physical activity.

    Time frame: Baseline, 8 weeks (end of intervention), 3 months and 6 months (post-intervention)

  9. Net Promoter Score (NPS)

    The Net Promoter Score (NPS) will be used to measure the participants' satisfaction. A Net Promoter Score (NPS) is a customer loyalty and satisfaction metric that measures how likely a person is to recommend a company, product, or service to a friend or colleague. Businesses ask one simple survey question: "On a scale of 0 to 10, how likely are you to recommend us?" Promoters (Score 9-10): Loyal and enthusiastic fans who will keep buying and tell others. Passives (Score 7-8): Satisfied customers who are unenthusiastic and vulnerable to competitors. Detractors (Score 0-6): Unhappy customers who can damage your brand through negative word-of-mouth

    Time frame: 8 weeks (end of the intervention)

07

Study locations

1 of 1 sites recruiting
  • Executive Park
    Atlanta, Georgia 30329, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Sep 2028, 36 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 36 months is above that.

Counting every sponsor, half of 518 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2026
First posted
Sep 17, 2026
StartActual
Sep 29, 2025
Primary completionEst.
Sep 2028
CompletionEst.
Sep 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 time frame changed, 2 description edited
What changed in the outcomes
  • Time frameNumber of participants who complete the intervention3 months and 6 months post-intervention → 8 weeks
  • DescriptionAdherence to program: how it is measured was reworded
  • DescriptionNumber of participants who complete the intervention: how it is measured was reworded
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Primary outcomes 1 time frame changed, 2 description edited
    What changed in the outcomes
    • Time frameNumber of participants who complete the intervention3 months and 6 months post-intervention → 8 weeks
    • DescriptionAdherence to program: how it is measured was reworded
    • DescriptionNumber of participants who complete the intervention: how it is measured was reworded
    + 2 other changes: verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07824141
Lead sponsor
Emory University
Collaborators
medbridge
Responsible party
Madeleine Eve Hackney (Assistant Professor of Medicine, Emory University) — Principal investigator
First posted
Sep 17, 2026
Start date
Sep 29, 2025
Primary completion
Sep 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Madeleine E. Hackney, Ph.D.
Contact
mehackn@emory.edu
314-412-4852
Madeleine E. Hackney, Ph.D.
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion